New York Life Trust’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$4K Sell
16
-80
-83% -$19K 0.19% 140
2016
Q4
$22K Sell
96
-67
-41% -$15.6K 0.1% 177
2016
Q3
$35K Buy
+163
New +$35.3K 0.17% 155
2015
Q3
Sell
-88
Closed -$14K 228
2015
Q2
$14K Sell
88
-270
-75% -$43.2K 0.06% 180
2015
Q1
$58K Buy
+358
New +$57.2K 0.23% 136
2014
Q2
Sell
-1,113
Closed -$137K 215
2014
Q1
$137K Buy
1,113
+1,072
+2,615% +$127K 0.61% 52
2013
Q4
$5K Sell
41
-142
-78% -$15.2K 0.02% 184
2013
Q3
$17K Sell
183
-1,359
-88% -$126K 0.09% 165
2013
Q2
$128K Buy
+1,542
New +$120K 0.59% 49

Other funds holding NOC

New York Life Trust's NOC Position: Q1 2017 in Review

New York Life Trust reduced its Northrop Grumman (NOC) stake by 83% in Q1 2017, selling an estimated $19K and leaving 16 shares worth $4K. The position accounts for 0.19% of the portfolio, ranked #140.

New York Life Trust first reported a position in NOC in Q2 2013 and has held it in 9 quarters since. The position peaked at $137K in Q1 2014. 890 funds tracked by Wall St. Rank hold NOC as of Q1 2017.

  • New York Life Trust held 16 shares of Northrop Grumman worth $4K as of Q1 2017.
  • New York Life Trust sold 80 Northrop Grumman shares in Q1 2017, an estimated $19K.
  • Northrop Grumman made up 0.19% of New York Life Trust's portfolio in Q1 2017, its #140 holding.
  • New York Life Trust first reported a position in Northrop Grumman in Q2 2013 and has held it in 9 quarters since.
  • New York Life Trust's Northrop Grumman position peaked at $137K in Q1 2014.
  • 890 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.